SARS-CoV-2 mRNA vaccination in lactating mothers: an observational study to assess longer-term immune responses in blood and breast milk, infections and health status after coronavirus (COVID-19) mRNA vaccination in Zurich, Switzerland
Not Applicable
Completed
- Conditions
- COVID-19 (SARS-CoV-2 infection)Infections and Infestations
- Registration Number
- ISRCTN12344753
- Lead Sponsor
- niversity of Zurich
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 45
Inclusion Criteria
1. Lactating women receiving any of the mRNA SARS-CoV-2 vaccines approved in Switzerland at the Corona Center of the UZH
2. Aged =18 years
3. Able to follow the study procedures
4. Providing informed consent
Exclusion Criteria
1. Non-lactating individuals
2. Having insufficient knowledge of the German language
3. Previously received SARS-CoV-2 vaccine
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method